Financial Assistance Options for IPF Patients | Esbriet® (pirfenidone)
OpenVerified·Apr 24, 2026
- Covers
- financial assistance
- Max award
- $25,000
- Enrollment cycle
- rolling
Eligibility
Applicants must be U.S. residents aged 18 or older with a valid prescription for an FDA-approved use of Esbriet. Eligibility includes those with commercial insurance for the co-pay program or uninsured/underinsured patients meeting specific household income thresholds for the Legacy Patient Program.
Apply
Application goes directly to the program. RxCopays does not receive compensation.
Go to application →Status source
Apply for the Esbriet Co-pay Program
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: